Cargando…
Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance
Despite numerous reports on the altered sphingolipids metabolism in human cancers, their clinical significance in breast cancer remains obscure. Previously, we identified the high levels of sphingolipids, ceramide phosphates and sphingosine phosphates, and the genes involved in their synthesis, CERK...
Autores principales: | Bhadwal, Priyanka, Randhawa, Vinay, Vaiphei, Kim, Dahiya, Divya, Agnihotri, Navneet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617946/ https://www.ncbi.nlm.nih.gov/pubmed/36309544 http://dx.doi.org/10.1038/s41598-022-20976-0 |
Ejemplares similares
-
LC-HRMS based approach to identify novel sphingolipid biomarkers in breast cancer patients
por: Bhadwal, Priyanka, et al.
Publicado: (2020) -
Presence of LYM2 dependent but CERK1 independent disease resistance in Arabidopsis
por: Narusaka, Yoshihiro, et al.
Publicado: (2013) -
Alterations in Lipid Mediated Signaling and Wnt/β-Catenin Signaling in DMH Induced Colon Cancer on Supplementation of Fish Oil
por: Kansal, Shevali, et al.
Publicado: (2014) -
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
por: Hatoum, Diana, et al.
Publicado: (2017) -
Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells
por: Rajput, Kajal, et al.
Publicado: (2022)